Cascade eyes AcuNetx purchase for optical tech growth
This article was originally published in Clinica
Executive Summary
Imaging firm Cascade Technologies is aiming to boost its product portfolio after signing a letter of intent to purchase AcuNetx. As well as serving the law enforcement, communications and workplace safety industries, AcuNetx manufactures diagnostic, analytical and therapeutic devices that help healthcare providers diagnose and treat balances disorders and bone deficiencies. Cascade (Beverly Hills, California) described these technologies as being complementary to its own range of medical imaging products, which includes noninvasive imaging systems, originally developed for satellite reconnaissance, but now used to diagnose cancer and precancerous conditions. Financial terms within the letter of intent were not disclosed.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals